Gushang Xia
Research Subjects
Gushang Xia has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Honggang Luo
Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China
1 shared publicationJiannan Shao
Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China
1 shared publication- Qingli Kong
Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China
1 shared publication - Rong Yang
Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China
1 shared publication Shenyu Luo
Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China
1 shared publicationXianglin Li
Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China
1 shared publication
Latest Publications
- Open Access
- 2 October 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (40) , e50961
Sex hormone–binding globulin increases lumbar fracture risk via bone density, inflammation, and insulin pathways
Circulating sex hormone–binding globulin (SHBG) regulates bioavailable sex hormones that influence bone metabolism. We investigated whether genetically higher SHBG increases lumbar fracture (LF) risk and identified the biological pathways mediating this effect, including bone mineral density (BMD), C-reactive protein (CRP), and insulin use. A two-sample bidirectional and mediation Mendelian randomization (MR) framework was applied using genome-wide significant single-nucleotide polymorphisms ( P < 5 × 10 −8 ) from large-scale genome-wide association study datasets (FinnGen, UK Biobank, and IEU OpenGWAS). Instrumental variables were linkage disequilibrium-pruned ( r 2 < 0.01), and analyses were conducted using inverse-variance weighted, MR-Egger, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier methods. Genetically predicted SHBG was causally associated with higher LF risk (FinnGen: odds ratio [OR] = 1.201; 95% confidence interval, 1.028–1.404; P = .021; UK Biobank: OR = 1.005; 95% confidence interval, 1.002–1.008; P = .002). SHBG showed significant negative effects on lumbar BMD (OR = 0.934; P = .0029) and CRP (OR = 0.921; P = .0065), and a modest decrease in insulin medication use (OR = 0.9963; P = 6.1 × 10 −6 ). Mediation analysis revealed that 64.8% of SHBG’s total effect on LF was mediated through BMD, 63.8% through CRP, and 38.7% through insulin pathways. Sensitivity tests confirmed robustness without evidence of pleiotropy. Genetically elevated SHBG increases LF risk mainly through impaired bone density and systemic inflammation. These findings suggest that interventions targeting SHBG-related metabolic pathways may help reduce skeletal fragility.
- 2 October 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (40) , e50961
Open AccessSex hormone–binding globulin increases lumbar fracture risk via bone density, inflammation, and insulin pathways
Circulating sex hormone–binding globulin (SHBG) regulates bioavailable sex hormones that influence bone metabolism. We investigated whether genetically higher SHBG increases lumbar fracture (LF) risk and identified the biological pathways mediating this effect, including bone mineral density (BMD), C-reactive protein (CRP), and insulin use. A two-sample bidirectional and mediation Mendelian randomization (MR) framework was applied using genome-wide significant single-nucleotide polymorphisms ( P < 5 × 10 −8 ) from large-scale genome-wide association study datasets (FinnGen, UK Biobank, and IEU OpenGWAS). Instrumental variables were linkage disequilibrium-pruned ( r 2 < 0.01), and analyses were conducted using inverse-variance weighted, MR-Egger, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier methods. Genetically predicted SHBG was causally associated with higher LF risk (FinnGen: odds ratio [OR] = 1.201; 95% confidence interval, 1.028–1.404; P = .021; UK Biobank: OR = 1.005; 95% confidence interval, 1.002–1.008; P = .002). SHBG showed significant negative effects on lumbar BMD (OR = 0.934; P = .0029) and CRP (OR = 0.921; P = .0065), and a modest decrease in insulin medication use (OR = 0.9963; P = 6.1 × 10 −6 ). Mediation analysis revealed that 64.8% of SHBG’s total effect on LF was mediated through BMD, 63.8% through CRP, and 38.7% through insulin pathways. Sensitivity tests confirmed robustness without evidence of pleiotropy. Genetically elevated SHBG increases LF risk mainly through impaired bone density and systemic inflammation. These findings suggest that interventions targeting SHBG-related metabolic pathways may help reduce skeletal fragility.